Elasomeran is an mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus. Coronavirus disease 2019 (COVID-19) is a highly contagious infectious disease caused by the novel coronavirus, SARS-CoV-2, leading to a respiratory illness alongside other complications.
- Mechanism
- Curator reviewed · 3 references
The Moderna COVID-19 Vaccine is a vaccine that contains synthetic nucleoside-modified messenger RNA (mRNA) encapsulated in Lipid nanoparticle (LNP) which codes for the full-length, pre-fusion stabilized spike protein (S) of SARS-CoV-2. The S glycoprotein is a large transmembrane protein that plays a critical role in viral attachment, fusion, and entry into the host cell. Upon vaccination, human cells express the SARS-CoV-2 S antigen and immune response to the S antigen is elicited, leading to the protection against SARS-CoV-2.
- Primary indication
- The Moderna COVID-19 Vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older in the US...Curator reviewed · 7 structured indications
- First approval
- Canada, 2023 · United States, 2022 · European Union, 2021
- Also known as
- Moderna COVID-19 Vaccine · MRNA-1273 SARS-COV-2
- Code names
- CX-024414 · M-1273 · mRNA-1273
- Brand names
Resolves to
What you can answer from here — as of June 15, 2026
Which drugs share a target with Elasomeran, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account